期刊文献+

中药溃结灵配合柳氮磺胺吡啶对溃疡性结肠炎患者防御素、一氧化氮及丙二醛表达的影响 被引量:2

Effect of Kuijieling Decociton plus Sulfasalazine on HNP1-3,NO and MDA expressions in Ulcerative Colitis
下载PDF
导出
摘要 目的观察中药溃结灵煎剂对溃疡性结肠炎(UC)结肠组织HNP1-3、NO和MDA的影响,探讨其治疗机制。方法活动期UC(大肠湿热证)患者随机分为中西药结合组(予溃结灵、SASP)与柳氮磺胺吡啶组(予SASP),检测治疗前后肠黏膜组织内HNP1-3蛋白表达情况及结肠组织NO、MDA水平。结果随着病变程度的增加,HNP1-3、NO和MDA的表达逐渐增强,三者呈明显正相关;两组治疗后HNP1-3、NO和MDA表达较治疗前明显减少,治疗组的减少程度高于对照组。结论溃结灵配合SASP治疗能使NO和MDA对组织的细胞毒性降低,从而达到治疗溃疡性结肠炎的作用。 Objective: To probe into the correlation among HNP1-3,NO and MDA and these expression in ulcerative colitis(UC) with colorectal damp heat syndrome and to observe the effect of Kuijieling Decoction in the above indices and to investigate the mechanism of Kuijieling Decociton on in UC.Methods: Patients of active UC with damp heat syndrome were randomly divided into the combination group with Kuijieling Decociton plus SASP and the control group with SASP.The HNP1-3 protein expression was detected by S-P method.The NO and the MDA were detected by the nitrate reductase method and thiobarbituric acid(TBA) coloration.Results: The expression of HNP1-3 was significantly correlated with that of NO and MDA.In the combination group and the control group,expressions such as HNP1-3,NO and MDA after the treatment were decreased significantly compared with those before the therapy.There was a remarkable difference between the combination group and the control group after treatment.Conclusion: The cytotoxicity with NO and MDA could be reduced by the combination therapy.Also,the rate and the intensity of perosidation could be decreased by this method.Moreover,the damage with histocyte could be reduced to the lowest degree so that the histocyte could be restored to treat the ulcerative colitis.
出处 《中国中医急症》 2010年第10期1654-1655,1673,共3页 Journal of Emergency in Traditional Chinese Medicine
基金 广东省中医药局建设中医药强省科研课题(No.2009044)
关键词 溃疡性结肠炎 防御素 一氧化氮 丙二醛 溃结灵 Ulcerative colitis HNP1-3 NO MDA Kuijieling Decoction
  • 相关文献

参考文献7

二级参考文献11

  • 1陈治水,危北海,张万岱.溃疡性结肠炎中西医结合诊治方案(草案)[J].中国中西医结合杂志,2004,24(11):1052-1055. 被引量:177
  • 2中华人民共和国卫生部.中药新药临床研究指导原则(第二辑)[S].,1995.171-172.
  • 3中华人民共和国卫生部.中药新药临床研究指导原则(第二辑)[S].北京:人民卫生出版社,1995:122-125
  • 4Rodrigeus M ,Zerbini M C, Barbiern D. Immunonistochemical study of colonic mucosa macrophages in children with Crohn' s disease and ulcerative colitis[J].Arq Gastroenterol, 1995,35:283
  • 5Braegger C P, Nicholl S,Murch S H,et al. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation [ J ]. Lancet, 1992, 339:89
  • 6Bantel H, Domschke W, Schulze - Osthoff K, Kaskas B, Gregor M. Abnormal activation of transcription factor NF - kappaB involved in steroid resistance in chronic inflammatory bowel disease[ J]. Am I Gastroenterol 2000,95 : 1845 - 1846
  • 7Powell-Tuck J,Bown RL,Lennard-Jones JE.A comparison of oral prednisolone given as single or multiple daily doses for active protocolitis[J].Scand J Gast roenterol,19748,13:833-837.
  • 8Kaisho T,Akira S.Toll-like receptors and their signaling mechanism in innate immunity[J].Acta 0dontol Scand.2001,59:124-130.
  • 9Spitzer JH,Visintin A,Mazzoni A,et al.Toll-like receptor inhibits Toll-like receptor 4 signaling in endothelial cells[J].Eur J Immunol,2002,32:1182-1187.
  • 10Geng X,Taniguchi M,Dai HH,et al.Autoimmunity in ulcerative colitis:humoral and cellular immune respoese by tropomyosin in ulcerative colitis[J].World j Gastroenterol,2000,6(Suppl3):9.

共引文献185

同被引文献21

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部